http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1042283-A1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2de3beee83d9c19278da409b72c777a8 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C405-00 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C405-00 |
| filingDate | 1998-12-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8fedf88b663bc51b1d1e30b524fd8b47 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2ffc647dacb56be5ef6ab5579b5c33db |
| publicationDate | 2000-10-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | EP-1042283-A1 |
| titleOfInvention | $g(v)-CYCLOALKYL-PROSTAGLANDIN E 2? DERIVATIVES |
| abstract | omega-Cycloalkyl-prostaglandin E2 derivatives of formula (I)(wherein all symbols are as defined in the description);and non-toxic salts thereof, prodrugs thereof and cyclodextrin clathrates thereof.Compounds of formula (I) strongly bind on the EP2 subtype receptor. Therefore, they are useful for prevention and/or treatment of immunological diseases (autoimmune diseases, organ transplantation etc.), asthma, abnornmal bone formation, neuronal cell death, liver damage, abortion, premature birth or retina neuropathy of glaucoma etc. |
| priorityDate | 1997-12-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 104.